Description

The microstructure of solid dosage forms of pharmaceutical products is a critical factor that impacts disintegration and dissolution rates. As such, the microstructure will also play a key role in bioequivalence and therapeutic equivalence. Being able to image the microstructure of a solid dosage form allows optimization of production and formulation procedures to achieve a robust dissolution response. If an out-of-specification dissolution result is later observed, analysis of the solid dosage form’s internal structure and microstructure can yield a wealth of insights not accessible through traditional analytical approaches and help resolve mission-critical investigations. New product development can be a highly time-consuming and expensive task. Using Rigaku’s nano3DX, this process can be accelerated, providing immediate feedback on a product’s internal structure when any discrepancies between expected and actual attributes can be identified.

 

Read more 

 

 

Kontakt pro tuto analýzu

doc. Ing. Tomáš Zikmund, Ph.D.
doc. Ing. Tomáš Zikmund, Ph.D.
Junior Researcher
Osobní profil

Adresa

CEITEC Vysoké učení technické v Brně, Purkyňova 123
Najít trasu na Google mapách

Kontaktujte nás